Nyxoah says U.S. Pivotal Study meets primary safety, efficacy endpoints
Nyxoah SA said its U.S. Pivotal Study met the primary safety and efficacy endpoints in complete concentric collapse patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.